Welcome to article directory Rankology. Here You can find interesting and useful information on most popular themes.

There are 613 published articles and 1 registered authors in our article directory.

Recent Articles

Actos Warning Breaking News

By admin | Published January 26, 2012

Actos Warning : One study of municipal distribution of BC in Spain detected 34,281 BC deaths registered between 1989 and 1998. They could observe that determinate zones exhibited a higher risk than others, these being provinces of Cadiz, Seville, Huelva, Barcelona, and Almeria. The municipal mortality patterns suggested that the industrial and mining activity in the Provinces of Seville and Huelva could be associated with higher BC mortality in these provinces. The mortality pattern assessed in two different areas of the Province of Barcelona, which is only observable in women, might be related to the textile industry traditionally situated in these areas (Lopez-Abente et al. 2006).The trend to decrease BC due to occupational exposure was reported in a pooled analysis of 11 case-control studies on BC conducted in European countries between 1976 and 1996. This analysis included 3346 male cases and 6840 male controls. Thirty-one occupations showed increase risk for BC and these occupations were grouped as metal workers, textile workers, painters, miners, and transport opera­tors. Higher odd ratios were observed on those people with duration of employment more than 25 years. However, the author concluded that the ratio of BCs caused by occupational exposure was lower than those identified one year ago and that the exposure to occupational carcinogens had been reduced in the European Union.

 

More information on Actos Warning

This would likely be due to the improvement in working conditions and the reduction of exposure, particularly, to aromatic amines in work. Currently, employ­ments that relate more to BC risk are those in metal sector, machinists, transport operators, and miners (Kogevinas et al. 2003).In addition to the analysis on men, a pooled analysis of 11 case-control studies in BC conducted in Western Europe showed that the rates of BC due to occupa­tional exposure had been reduced in women, with only a 8% of BC in women attributable to occupational carcinogens (Mannetje et al. 1999). Although in devel­oped countries strict regulatory controls may have contributed to a decreased bur­den of exposure to bladder carcinogens in the workplace, the situation is less apparent in developing countries.

Information from other sources on Actos Warning

As in BC, in general, occupational case is more frequent in men than in women, although, an increased risk among women has been documented in several studies, including those employed in the rubber industry and, more recently, in healthcare settings. In a case-control study conducted in Iowa, female teachers, domestic ser­vice employees, and workers in laundering and dry-cleaning business had elevated risk of BC. Other gender and racial differences had been documented in occupa­tional BC. In this way, in a recent mortality study in the United States, the mortality ratios for AA men and women and Latino males in various occupations were found to be increased compared with workers of the same gender and ethnic-racial group (Delclos and Lerner 2008).

 

Our use of the term or terms Actos Warning is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Warning visit our site often.

http://www.seedol.com

Posted in Rankology | Tagged , |

Actos and Bladder Cancer News Flash

By admin | Published January 26, 2012

Actos and Bladder Cancer : Bladder cancer treatment can include surgery, chemotherapy, radiation therapy, and immunotherapy. Although some of these treatments are used alone, often a combination of several treatments (i.e., both chemotherapy and surgery) is used for the most success. Selection of the most appropriate treatment is based on clinical staging, including pathological and ra­diographic information, and individual preference in close consultation with your physician. When choosing a blad­der cancer treatment, it is important that you consider not only the potential for cancer cure but also the side effects and quality of life impact of various treatments.

More information on Actos and Bladder Cancer

SURGICAL TREATMENT

Surgery plays an important role in both the staging and subsequent treatment of bladder cancer. Transurethral resection of a bladder tumor (TURBT) is the initial treat­ment step in the vast majority of patients with bladder cancer. TURBT provides valuable staging information, and pathological results from these procedures are used to make further decisions regarding what, if any, addi­tional therapy is needed. The gold standard treatment for muscle-invasive bladder cancer is radical cystectomy (removal of the bladder). Advances in surgical technique and anesthesia have reduced the complications associated with this procedure in the last two decades. The develop­ment of continent urinary diversion, which allows one to empty the bladder through the urethra, is an option for certain patients. Minimally invasive procedures such as laparoscopic or robotic-assisted radical cystectomy may also be treatment options. In addition, bladder-sparing procedures (either with partial removal of the bladder or aggressive TURBT frequently in combination with che­motherapy and/or radiation therapy) have allowed some patients to treat their cancer while leaving their blad­ders intact. Advances in surgical techniques continue to this day with the development of minimally invasive approaches to cystectomy. Both robotic-assisted and lapa­roscopic radical cystectomy have been performed safely in highly specialized centers and have the potential for decreased morbidity and a shorter period of recovery, but longer term follow-up is needed to determine if these pro­cedures are equivalent to open surgical techniques.

 

Information from other sources on Actos and Bladder Cancer

TURBT is often the first procedure you will have once diagnosed with a bladder tumor. This surgery is typically performed under general or spinal anesthesia as an out­patient procedure and without any incision, endoscopically through the urethra, which means a cystoscope is placed through the urethra and into the bladder. Through this scope your urologist can see the inside of your bladder and has the ability to resect, or remove, tumors in the bladder under direct vision using electrocautery. The electrocautery is also used to control bleeding after the resection is com­pleted. TURBT is extremely important for the staging of bladder tumors but can also be therapeutic for lower stage bladder cancers. Once the tumor has been removed, it can be analyzed under the microscope by a pathologist. The pathological findings dictate further treatment decisions. If the tumor is low grade and noninvasive, you will likely not need any further therapy at this point except for close follow-up.

 

Our use of the term or terms Actos and Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos and Bladder Cancer visit our site often.

Actos and Bladder Cancer

Posted in Rankology | Tagged , |

Actos Side Effects Resources

By admin | Published January 26, 2012

Actos Side Effects: The bladder is a balloon-shaped, muscular organ tucked into the pelvis and held in place by fibrous bands and muscle. The bladder is part of a system that includes the kidneys, ureters, and urethra. These work to process the waste products left behind after your body has taken out the nutrients it needs from the food you eat.

The bladder is lined on the inside by a tissue known as “urotheli- um,” the smooth layer that stretches as the bladder fills and prevents excreted material from being reabsorbed into the body. Underneath the urothelium is a mix of fibrous or supporting tissue and muscle, both of which help the bladder to expand (when full) and to contract and excrete urine at the appropriate time.

Not only does the urothelium line the bladder; it also is found as the lining tissue elsewhere in the urinary tract system, including in the ureters (the tubes that drain the kidneys), the urethra (the tube that drains urine from the bladder to the exterior of the body), and parts of the male prostate. Urothelial tissue, too, can sometimes develop cancer­ous changes known as urothelial malignancy. The most common type of urothelial malignancy is “transitional cell carcinoma.” (See Chapter 3.)

It’s important to note that when the urothelial tissue is exposed to cancer-causing substances, such as the breakdown products of ciga­rette smoke, the potential exists for cancerous changes to occur in multiple areas. That’s why when bladder cancer is suspected or con­firmed, the whole urinary tract is screened for the possible presence of other cancerous deposits. Other organs, such as the lungs, liver, skin, and intestinal tract, also process waste. These systems work together to balance the chemicals and water that your body needs to function properly.

More information on Actos Side Effects

The urinary system processes urea, a specific waste product that is produced when protein-containing foods (such as a meat) are broken down in the digestive process.Urea is filtered through the kidneys and together with other waste by-products and water, becomes urine. This is carried by thin tubes called ureters to the bladder, where it is stored. Muscles in the walls of the ureters squeeze out small amounts of urine into the bladder on a constant basis, about every 10 seconds. A healthy bladder can hold about two cups of urine for up to five hours. Healthy adults produce about six cups of urine a day.

A strong muscle somewhat like a rubber band circles your bladder and keeps the urethra tightly closed until nerves in the bladder signal you that the bladder is full and it is time to urinate. Urinary problems include the inability to retain the urine in the normal fashion or to void urine from the body. Sometimes people experience the urge to urinate even if the bladder is not full. Sometimes this is caused by bacteria in the bladder, which can cause an infection called cystitis. This symptom can also be caused by local bladder irritation or by the development of cancer. As with all parts of the human body, the bladder can develop cancer, which can also cause problems with retaining or voiding urine.

The most common symptom of bladder cancer is hematuria, or blood visible in the urine, either with or without any accompanying pain. About 85 percent of the people diagnosed with bladder cancer notice blood in their urine, and it’s often what prompts them to seek med­ical attention.

In some cases, the presence of blood isn’t noticeable to the naked eye and can only be seen through a microscope, usually when a urine test is being done during a routine physical or when an infection of the urinary tract or bladder is suspected. A urine test can detect whether blood is present in the urine and can also rule out whether other things, such as food or medicines, are the cause of red or rusty-colored urine.

Information from other sources on Actos Side Effects

Noticeable blood in the urine is a tricky symptom. It appears in varying colors and at irregular intervals, and as a result, you might overlook its significance or decide to wait and see whether it happens again before checking it out. For example, you may notice blood in your urine or drops of blood in your underwear two or three times in as many days, or you may see it on one occasion but after that your urine appears normal for days or weeks. The same thing can happen with a laboratory urinalysis, where red blood cells may be visible microscopically only intermittently.

You might experience a gush of With the major symptoms bright red blood or notice pink or rusty of bladder cancer acting in brown urine or even little clots of such a variable fashion, blood. To complicate things even appearing in different ways more, foods you eat such as beets or and sometimes disappearing blackberries may produce colored altogether, it’s important to urine, as do a number of medicines, see your doctor immediately food additives, and vitamins. If you notice blood or what

With the major symptoms of bladder you think might be blood in cancer acting in such a variable fash- your urine. ion, appearing in different ways and sometimes disappearing altogether, it’s important to see your doctor immediately if you notice blood or what you think might be blood in your urine. As with most cancers, the key to successfully managing bladder cancer is detecting it early and starting treatment as soon as possible.

Bladder cancer does not have a long list of symptoms, and many of the symptoms are typical of other, less severe conditions such as infections or benign tumors. Besides blood in the urine, your symp­toms can include pain or burning during urination, a feeling of having to urinate because of an uncomfortable fullness, or the need to get up frequently at night to urinate. You may also have symptoms such as backache, abdominal pain, and unplanned weight loss, or you may feel more tired and achy than usual.

Our use of the term or terms Actos Side Effects is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Side Effects visit our site often.

Actos Side Effects

Posted in Rankology | Tagged , |

Actos Bladder Cancer Release

By admin | Published January 26, 2012

Actos Bladder Cancer : Despite prompt and appropriate medical treatment if you have mus­cle-invasive TCC, there is about a 50 percent chance that your cancer will metastasize (spread), either to another organ in the body or with­in the bladder area itself. The most common sites of “distant metastasis” (not in the imme­diate area of the bladder) are the para-aortic lymph nodes and the liver, lungs, and bone. Occasionally, bladder cancer can send deposits through the bloodstream to the brain, but usually this happens only after prolonged and repeated treatment. Most recurrences, both dis­tant and local, occur within the first two years after treatment.

One point worth emphasizing is that cancer cells in a distant metastasis still have the characteristics of the bladder cancer (i.e., they behave in the pattern of those bladder-cancer cells and don’t really constitute ” bone cancer”or “liver cancer”as such).Thus the drugs that may work against bladder-cancer cells also have a chance of working against these metastases located at other sites in the body.

As you might expect, the metastasis of your cancer is a dangerous situation that reduces your chance of a permanent cure. That doesn’t mean that cure is impossible or that you no longer have options. Some established chemotherapy approaches can sometimes achieve cure if the metastases are not too extensive. In addition, new and promising therapies, including novel chemotherapy drugs, are under­going clinical trials as this book goes to print, and many of those may well be available to you.

More information on Actos Bladder Cancer

When metastasis occurs, the direction of your treatment shifts somewhat from a totally focused attempt to achieve cure. In this situ­ation/ while we attempt to cure the metastatic cancer if possible/ we also tty to palliate (reduce) the symptoms and we place a greater emphasis on comfort and pain control This type of treatment is called palliative care. At this point, not only you but your family and loved ones should be involved with your medical team in understanding the progression of your disease and making decisions about your care.

This is a very important point and it can be confusing. On the one hand, your medical team is still trying very actively to cure the cancer, if possible, and to prolong your life and improve its quality to the maximum extent. However, as the chance of cure is somewhat small­er, you and your medical team must also give thought to the benefits and drawbacks of treatment, to quality-of-Hfe issues, and to making the decisions that make the most sense. You and they will want to weigh the chance that treatment might be successful against the possible side effects, the time spent in treatment, and the possible limitations on your quality of life.Your doctor may discover the metastasis during a routine check­up, although sometimes a patient will experience symptoms.

Information from other sources on Actos Bladder Cancer

might be bone pain, abdominal discomfort severe headache, or tin­gling in the legs. (The latter may occur if a metastasis is pressing on nerves in the spine.) Perhaps weight has been lost without changing exercise or diet habits. One might develop a cough or abdominal pain, or experience hematuria (blood in the urine) or other symp­toms of bladder irritation. Any of these symptoms should send you to the phone to make an appointment with your doctors to figure out whether something sin­ister is beginning to occur. As you read this you might be thinking that if the cancer is so advanced – if it has spread to the lungs or bones what’s the point of treating symptoms like tingling in your legs or vague abdominal pain?

The point is that even though the cancer has advanced and metas­tasized, you are likely to live for an extensive period of time – months or years – and it makes good sense to make sure that you are able to live that time comfortably and as fully as possible. If you allow symp­toms to go untreated, your ability to participate in everyday life with your family and friends may be greatly diminished, and the time you have left with them may be cut short. On the other hand, occasionally a specialist may decide to watch and wait. For example, when a change is seen on an x-ray but there are no symptoms. Or when a patient is unwell from other medical problems or is just keen to avoid treatment at that time. In such situ­ations, sometimes the decision will be made to observe closely and start treatment when symptoms occur.

What kind of treatment can one expect if the cancer metastasizes? Surgery to remove the bladder is occasionally a possibility if the only site of recurrence is the bladder and surrounding tissues. It usually doesn’t make sense to operate if the cancer has spread to distant sites. Sometimes radiotherapy will be used to reduce the symptoms of recurrence in the bladder if the recurrence is too extensive to permit surgery or if distant metastases have also occurred.

Our use of the term or terms Actos Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Bladder Cancer visit our site often.

Actos Bladder Cancer

Posted in Rankology | Tagged , |

Lawsuits Report

By admin | Published January 24, 2012

Lawsuits: Discovery control in complex litigation may take a variety of forms, in­cluding time limits, restrictions on scope and quantity, and sequencing. The Federal Rules and the court’s inherent power provide the court with broad authority. Among other provisions, Federal Rule of Civil Procedure 16(b) di­rects the court to limit the time for discovery, and Rule 26(b) empowers the court to limit the “frequency or extent of use of the discovery methods” under the rules, including the length of depositions. Rule 30(a) imposes a presump­tive limit of ten depositions per side. Rule 30(d) has a presumptive durational limit of one 7-hour day for any deposition. Rule 33 establishes a presumptive limit of twenty-five interrogatories per party (see sections 11.451, 11.462). Rule 26(f)(3) requires the parties to address discovery limits in their proposed dis­covery plan. Propecia Lawsuit

Presumptive limits should be set early in the litigation, before discovery has begun. Information about the litigation will be limited at that time, so lim­its may need to be revised in the light of later developments. But they should be imposed on the basis of the best information available at the time, after full consultation with counsel, and with the understanding that they will remain binding until further order. In determining appropriate limits, the court will need to balance efficiency and economy against the parties’ need to develop an adequate record for summary judgment or trial. This task further underlines the importance of clarifying and understanding the issues in the case before imposing limits.

The discovery plan should include a sched­ule for the completion of specified discovery, affording a basis for ju­dicial monitoring of progress. Setting a discovery cutoff date113 is an important objective, but may not be feasible at the initial conference in complex litigation. The discovery cutoff should not be so far in ad­vance of the anticipated trial date that the product of discovery be­comes stale and the parties’ preparation outdated. Time limits impose valuable discipline on attorneys, forcing them to be selective and helping to move the case expeditiously, but standing alone they may be insufficient to control discovery costs. Unless time limits are com­plemented by other limitations, attorneys may simply conduct multi­track discovery, thereby increasing expense and prejudicing parties with limited resources. To prevent time limits from being frustrated, the judge should rule promptly on disputes so that further discovery is not delayed or hampered while a ruling is pending. Although attorneys will sometimes argue over “priorities,” the rules provide for no such presumptive standing.

For more information on Lawsuits follow us on our RSS Feeds.

Time limits may be complemented by limits on the number and length of depositions, on the number of interrogatories, and on the volume of requests for production. Imposing such limita­tions only after hearing from the attorneys makes possible a reasona­bly informed judgment about the needs of the case. Limitations are best applied sequentially to particular phases of the litigation, rather than as aggregate limitations. When limits are placed on discovery of voluminous transactions or other events, consider using statistical sampling techniques to measure whether the results of the discovery fairly represent what unrestricted discovery would have been expected to produce (section 11.493 discusses statistical sampling). Phased, sequenced, or targeted discovery. Counsel and the judge will rarely be able to determine conclusively early in the litigation what discovery will be necessary; some discovery of potential relevance at the outset may be rendered irrelevant as the litigation proceeds, and the need for other discovery may become known only through later developments. For effective discovery control, initial discovery should focus on matters—witnesses, documents, information. Actos Lawsuit

As the litigation proceeds, this initial discovery may render other discovery unnecessary or provide leads for further necessary dis­covery. Initial discovery may also be targeted at information that might facilitate settlement negotiations or provide the foundation for a dispositive motion; a discovery plan may call for limited discovery to lay the foundation for early settlement discussions. Targeted discovery may be nonexhaustive, conducted to produce critical information rapidly on one or more specific issues. In permitting this kind of dis­covery, it is important to balance the potential savings against the risk of later duplicative discovery should it be necessary to resume the deposition of a witness or the production of documents. Targeted dis­covery may in some cases be appropriate in connection with a motion for class certification; however, matters relevant to such a motion may be so intertwined with the merits that targeting discovery would be in­efficient. Where the scope of the litigation is in doubt at the outset—as, for example, in antitrust litigation—the court should consider limiting discovery to particular time periods or geo­graphical areas, until the relevance of expanded discovery has been established.

Sequencing by parties. Although discovery by all parties ordinarily pro­ceeds concurrently, sometimes one or more parties should be allowed to proceed first. For example, if a party needs discovery to respond to an early summary judgment motion, that party may be given priority. Some judges establish periods in which particular parties have exclu­sive or preferential rights to take depositions, and in multiple litiga­tion, those judges direct that discovery be conducted in some cases before others. Sometimes judges order “common” discovery to pro­ceed in a specified sequence, without similarly limiting “individual” discovery in the various cases.

Information from other sources on Lawsuits

The court may limit the par­ties to supplemental discovery if those materials will be usable as evi­dence in the present litigation. Interrogatory answers, depositions, and testimony given in another action ordinarily are admissible if made by and offered against a party in the current action. Similarly, they may be admissible for certain purposes if made by a witness in the current action.115 Coordination of “common” discovery in related litigation may also save costs, even if the litigation is pending in other courts. If related cases are pending in more than one court, coordinated com­mon discovery can prevent duplication and conflicts. A joint discovery plan can be formulated for all cases, with agreement among parties that one of the cases will be treated as the lead case (with its discovery plan serving as the starting point for development of supplemental plans in the other courts), or with the use of joint deposition notices. See section 20. Counsel may also agree that discovery taken in one proceeding can be used in related proceedings as though taken there.

In multiparty cases with no des­ignated lead counsel, judges sometimes require parties with similar positions to submit a combined set of interrogatories, requests for production, or requests for admission. If voluminous materials are to be produced in response, the responding party may be relieved of the requirement of furnishing copies to each discovering party. Sec­tion 11.44 has further discussion of document discovery, including use of document depositories.

Our use of the term or terms Lawsuits is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Lawsuits visit our site often.

http://www.seedol.com

Posted in Rankology | Tagged , |

Mesothelioma Lawsuit Legal News

By admin | Published January 24, 2012

Mesothelioma Lawsuit : A thoracoscopy can provide information crucial for deciding how to treat the patient. It gives great insight. Lastly, if the radiologic tests indicate that there is more solid tumor than fluid, or if there is no longer a space where fluid can accumulate because of previous attempts to control the fluid, an “open” biopsy may be indicated. The incision does not have to be large if the pleura is thickened, but the procedure should be per­formed by a thoracic surgeon who understands the principles of mesothelioma treatment. This surgeon will usually suggest a 3- or 4-inch incision on the side of the chest, overlying an area of pleura that is thickened. The surgeon may or may not remove a small piece of rib at this site to allow a direct view of the thickened pleura. Many times, a good-sized piece of pleura (1 to 1 1/2 inches in diameter) can be removed at this site. Getting a quick freeze of the tis­sue in the operating room, with the pathologist look­ing at the biopsy, will ensure that there’s enough tissue to perform all the required testing and to make a diagnosis. Surgeons performing these biopsies should pick the right place for the biopsy, and the cut (inci­sion) for this biopsy should be in line with the longer incision that would be used later if the patient is a surgical candidate. That way, this shorter incision can be removed.

For more information on Mesothelioma Lawsuit follow us on our RSS Feeds.

Although this operation is performed under general anesthesia (putting the patient to sleep), many times a chest tube to drain the air out of the chest is not needed because the surgeon never enters the chest cav­ity itself. The patient may need some pain medicine for about a week after the procedure if he or she was not having pain before the biopsy. Finally, mesothelioma can “set up shop” and grow tumors at biopsy sites. Radiation therapy is sometimes used after a thoracoscopy or open biopsy to prevent the disease from growing at those sites. If the biopsy results indicate mesothelioma, discuss this option with your physician.

Information from other sources on Mesothelioma Lawsuit

You need to make sure that the diagnosis in your case is correct, and you have every right to ask certain specific questions about the biopsy. Since mesothe­lioma is not a common disease, your primary doctor should make sure that all the appropriate testing has been performed on the specimen, including special stains (those immunos we talked about before), in order to distinguish mesothelioma from other cancers like adenocarcinoma of the lung. If there is any ques­tion, a common practice is to send the slides of the biopsy to specialists in mesothelioma.

It is important that you get the best information avail­able regarding your particular condition in order to decrease confusion, establish confidence in the treat­ment team, and have every opportunity to fight the disease and live as long as possible. In the majority of cases, your physician -will inform you whether the institution he or she is associated with has a special interest in the disease and treats more than 50 cases of mesothelioma per year. If those resources are not at your physician’s disposal, he or she should recommend a second opinion at a cancer center, which is a spe­cialized institution to which he can refer you for mesothelioma. You should not lose your primary physician or the physician who made this initial diag­nosis as your advocates.

Our use of the term or terms Mesothelioma Lawsuit is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Mesothelioma Lawsuit visit our site often.

http://www.seedol.com

Posted in Rankology | Tagged , |

Actos and Bladder Cancer Action

By admin | Published January 24, 2012

Actos and Bladder Cancer : An intravenous pyelogram (IVP) is an X-ray study that shows the general outline of the kidneys and better detail of the collecting system than an ultra­sound. X-ray contrast is given to the patient intra­venously. The kidneys then filter and concentrate the contrast, creating an image on an X-ray taken a few minutes after the injection is given. A small tumor or stone inside the collecting system can be seen as a dark spot inside the collecting system. Historically, the IVP was a common test to evaluate upper tracts. However, due to the decreased cost of CT scans and the increased availability, it has largely been replaced by CT scanning.

CT scanners use X-rays to create a detailed image of the internal organs. The scanner takes many X-rays at once and uses a computer to combine all of the images into the one picture that you see. When getting a CT scan of the kidneys, the patient is usually scanned three times. The first scan is per­formed without contrast and will reveal any kidney stones. The second scan is performed with contrast, which helps to show tumors in the kidneys. The third scan is obtained a few minutes later, after the kidney has had time to process the contrast. The contrast fills the collecting system similar to the IVP but with greater detail. A CT scan is very good for seeing tumors in both the kidneys and the col­lecting system. In addition to the ability to see the kidneys and ureters better, the CT scan allows for visualization of the entire abdomen and lymph nodes, helping to identify metastases or unrelated diseases. Over the last several years, the cost of CT scans has come down, and the availability of scan­ners to patients has increased, making the CT scan the most common upper tract study. As with the IVP test, CT scans meant to examine the kidneys

For more information on Actos and Bladder Cancer follow us on our RSS Feeds.

Although ureteroscopy is not technically an “upper tract study,” it gives us the most definitive examina­tion. It is similar to cystoscopy but uses a smaller scope. In the operating room or well-equipped office, the ureteroscope is carefully passed into the ureter as it opens into the bladder. This allows the urologist to see the inside of the ureter. It is gently passed all of the way up the ureter into the kidney. Like cys­toscopy, there are both rigid and flexible uretero- scopes. The flexible scope allows doctors to see all or most of the deep corners of the collecting system within the kidney. Biopsies of any suspicious areas can be taken and sent to pathology for analysis. Although ureteroscopy provides the best view of the collecting system, it usually requires anesthesia, and there is some small risk of damage to the kidney or ureter; thus, it is usually reserved for those patients who have had an abnormal upper tract study.

Information from other sources on Actos and Bladder Cancer

Cysview (hexaminolevulinate hydrochloride, GE health­care) has recently been approved as an optical imaging agent for use in the cystoscopic detection of non-muscle invasive papillary bladder cancer among patients sus­pected or known to have lesion(s) on the basis of prior cystoscopy. When used in combination with blue light (fluorescence) cystoscopy (Karl Storz D-Light C Pho­todynamic Diagnostic [PPD] system) it identified at least 1 more noninvasive papillary bladder tumor than rou­tine cystoscopy in about one third of the patients with such tumors. It is also useful in detecting carcinoma in situ, identifying 28% more patients with carcinoma in situ than standard cystoscopy.

Urine cytology is commonly used to screen for bladder cancer in patients who have hematuria as well as to monitor for recurrences in patients who are being treated for bladder cancer. Overall, urine cytology is able to detect 40% to 60% of bladder cancers, but the ability of cytology to detect a tumor varies depending on the grade, stage, and location of the tumor. In low-grade, low- stage tumors, cytology will detect only 25% to 40% of the tumors. It will perform better as the grade and stage of the tumor increase, with the best detection rate being for carcinoma in situ. Cytology detects approximately 90% of cases of carcinoma in situ.

Our use of the term or terms Actos and Bladder Cancer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos and Bladder Cancer visit our site often.

http://www.seedol.com

Posted in Rankology | Tagged , |

Multaq Lawyer Information

By admin | Published January 24, 2012

Multaq Lawyer: The first hepatitis virus to be discovered, hepatitis B (HBV), has infected an estimated 2 billion people worldwide. About 300 million are chronic carriers of the virus, including about 1.25 million Americans. HBV can be deadly; its complications kill about 1 million people every year, and it is the most prevalent cause of cirrhosis and liver cancer in the world, particularly in Africa and Southeast Asia. Yet most people infected with HBV lead fully normal lives.

For more information on Multaq Lawyer follow us on our RSS Feeds.

The HBV virus can be found in body fluids, including saliva, blood, tears, and breast milk, though it is transferred between people only through blood and semen. Casual contact, such as hugging or shaking hands, does not spread the disease; in fact, not everyone infected with HBV is contagious. HBV can be con­tracted only through sexual contact, a blood exchange, or from a pregnant mother to her fetus—a method of transmission common in Africa and Asia.

Before 1975, blood and platelets collected from blood donors (during blood drives, for example) were not screened for HBV so transfusions once accounted for many HBV infections in this country. Today, donated blood is tested for HBV, but the virus continues to be transferred through more subtle blood exchanges, such as when an infected person shares a razor or nail clippers, or exposes another person through a bleeding skin condition.

Information from other sources on Multaq Lawyer

Needles used for tattooing and acupuncture can also be contaminated with blood infected with HBV. People diagnosed with hepatitis B need to take special care to cover any bleeding spots, and everyone should avoid contact with used needles. The HBV virus can live on an open surface, including needles, for up to a week. In the United States, HBV is most often transmitted through sexual contact with an HBV carrier.

Immunization is key to preventing hepatitis B. People who have been vaccinated are virtually 100 percent protected, so HBV is a disease that could be eliminated. For now, though, its important for individuals at risk to take precautions. Health-care workers, any­one who received a blood transfusion before 1975, and anyone who lives with (or is sexually intimate with) an HBV-infected person are candidates for screening. In fact, it is recommended that sexually active homosexual men, intravenous drug users, dialysis patients, and anyone who has more than one sex partner within six months be screened for HBV. Anyone who receives results that indicate he or she is not immune should receive the vaccine series.


Our use of the term or terms Multaq Lawyer is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Multaq Lawyer visit our site often.

http://www.seedol.com

Posted in Rankology | Tagged , |

Ocella Lawsuit News

By admin | Published January 24, 2012

Ocella Lawsuit News: Diastole is divided into four phases: isovolumic relaxation, early rapid diastolic filling, diastasis, and late diastolic filling secondary to atrial contraction. At the cellular level, repolarization causes the cardiomyocyte to relax by the reuptake of calcium back into the sarcoplasmic reticulum via an energy-dependent process. When repolarization begins, calcium dissociates from the troponin I7T/C complex, and a conformation change occurs. The troponin I/T/C complex and the abutting tropomyosin then block myosin heads from binding to the active site on actin, thus ending muscle con­traction. The cardiomyocyte then returns to its resting shape given its viscoelastic properties. Diastole ends when the cardiomyocyte is again depolarized, calcium is extruded from the sarcoplasmic reticulum and binds with the troponin I/T/C complex, allowing the tropomyosin to move from the active actin-binding site and allowing the myosin heads to interact and move up the actin fibrils causing muscle contraction.

At the microscopic level, abnormalities of calcium homeostasis, reduction of the ATP/ADP ratio, and changes in the cytoskeleton and extracellular matrix constitution and geometry also contrib­ute to diastolic dysfunction. The cardiomyocytes of HFPEF patients have been shown to have almost twice the resting tension of normal patients at the same sarcomere length. This finding is thought to be due to a reduction in sarcomere protein phospho- ralation. In addition, a higher collagen volume fraction is found outside the myocytes, suggesting that there may be an imbalance of matrix metalloproteinases and their tissue inhibitors, resulting in decreased extracellular matrix degradation, Compared with the myocardial structure in SHF, cardiomyocytes in HFPEF have increased diameter and passive force. Cardiomyocytes of SHF have equal collagen volume fraction and less myofibrillary den­sity. Reduction in the absolute ATP and ATP/ADP ratio, which also occurs in advanced HF, is thought to contribute to diastolic dysfunction as cardiomyocyte relaxation is an energy-dependent process requiring the use of ATP to reuptake calcium ions into the sarcoplasmic reticulum so that the myosin heads will detach from the actin filaments.

More information on Ocella Lawsuit:

To improve symptoms, one of the key treatments is reducing pulmonary venous pressure. This can be achieved through a low salt diet and fluid restriction, and/or through diuretics and nitrates (which act to reduce central blood volume). ACE inhibitors, angi­otensin receptor blockers (ARBs), or aldosterone antagonists also help prevent fluid from accumulating by blocking neurohumeral activation. This benefit of ARBs impacts hospital admissions and exercise performance. In the CHARM-Preserved trial, candesartan was shewn to significantly decrease the number of hospital admis­sions, although cardiovascular mortality was unchanged.22 Blood pressure, when elevated, can also impair diastolic performance. Losartan has been shown to improve exercise performance of those HFPEF patients with a hypertensive response to exercise.36 Tachycardia may exacerbate HFPEF symptoms, and, if present, needs to be treated.

For the heart to relax, which results in higher filling pressures, and subsequently higher pulmonary pressures creating the signs and symptoms of HF. Tachycardia can also increase the myocai- dial oxygen demand further delaying relaxation, as relaxation is an energy-dependent process. Aerobic exercise in moderation may improve cardiovascular function and reduce the heart rate. Tachycardia can also be treated with beta blockers and nondihy­dropyridine calcium channel blockers.27 Verapamil, in specific, has been shown in a small study to statistically improve peak filling rate as well as exercise capacity of HFPEF patients.” If tachycardia is present in the setting of atrial fibrillation or flutter, cardioversion to a sinus rhythm may improve symptoms by pro­viding additional atrial preload.

Information from other sources on Ocella Lawsuit:

When valvular dysfunction is the underlying cause of heart failure, its identification permits directed medical and/or surgical treatment that can change patient morbidity and mortality by improving patient symptoms and cardiac function. Thus, its prompt identifica­tion is important when evaluating a patient with new or worsening heart failure. The nature of the clinical presentation and cardiac dysfunction varies depending on the valve involved, its defect, and the precipitating cause. Here, we attempt to help readers understand the mechanism for heart failure that accompanies the various forms of valvular disease and its correlation with the clinical presentation. We will also outline the major underlying causes, physical exam find­ings, diagnostic testing, and treatment for each of the major forms of valvular dysfunction.

As aortic valve area decreases, there will eventually be physi­ologic decompensation that is accompanied by development of exertional dyspnea, angina pectoris, and syncope. A valve area less than 1 cm2 is generally considered to be “severe” stenosis, but the onset of symptoms is poorly predicted by valve area and can occur before or after this threshold is reached. The thickening ventricle requires increased diastolic filling pressures, which are transmitted to the left atrium and pulmonary vasculature. This is exacerbated by tachycardia since decreased diastolic filling time requires even higher filling pressures, thus producing high pulmonary pressures and consequent dyspnea with exertion. Angina is the result of an inability to meet the increased oxygen demand required by the thick ventricle through vessels narrowed by the high transmural pressures and, often, concomitant atherosclerotic vessel disease. If cardiac contractility decreases or LV hypertrophy is insufficient to compensate for increasing afterload, cardiac output begins to decline. In this case, syncope may occur during exertion if the heart cannot generate the increased cardiac output required for sufficient cerebral perfusion in the setting of dilated vessels within exercising muscles. Prior to the wide availability of surgical valve repair or replacement, the mean amount of time between the first symptoms of AS and death was about three years, often occurring as a result of sudden cardiac death.

Ocella Lawsuit: More news about Ocella Lawsuit:

The primary treatment for symptomatic AS is aortic valve replacement (AVR). Severe AS with symptoms and/or LV systolic dysfunction (ejection fraction less than 50%) is a Class I indica­tions to perform AVR, as is the presence of severe AS in a patient who is undergoing CABG or surgery of the aorta or other heart valves according to an ACC/AHA panel of experts.1 Patients who have critical AS without symptoms should be monitored with annual echocardiograms, and they undergo surgery if LV systolic dysfunction develops. Balloon valuloplasty is an alternative that is primarily used in children with congenital, non-calcific AS. In adults, there is a high rate of restenosis, so it is usually reserved for palliation or as a “bridge” to surgery in patients who are too ill to undergo surgery.

In AR, regurgitation of a portion of the total stroke volume with each heartbeat compromises the effective forward stroke volume. In chronic AR, the effective forward stroke volume is maintained by increasing the total stroke volume. This is primarily achieved by LV dilatation and eccentric hypertrophy.7 In the early stage, these patients may experience palpitations in the chest or head, particularly with exertion, which may be quite uncomfortable for some. As LV dilatation progresses, the myocardium must gener­ate increasing wall tension to maintain sufficient cardiac output. Eventually, the LV cannot maintain a sufficient effective forward stroke volume, particularly during exertion. As this occurs, cardiac output may be normal at rest, but fails to rise normally with exer­tion, producing exertional dyspnea. Late in the disease, elevation in diastolic LV pressure caused by regurgitant flow causes second­ary elevation in LA, PA wedge, PA, and RV pressures.

Ocella Lawsuit: More information from other sources related to your search

Although surgery is the only definitive treatment, symptoms of heart failure can be improved with digitalis, salt restriction, diuretics, vasodilators, and ACE inhibitors. Long acting nifedipine has been shown to delay the need for surgery. Nitrates are typically not as helpful for angina as they are in ischemic cardiomyopathy, but may still provide some relief. Mitral stenosis (MS) is the result of valve leaflets being thickened by fibrous tissue and/or calcium deposits. The disease progresses over time as the thickened leaflets become further calcified due to immobilization. This is nearly always caused by rheumatic fever, thus its incidence appears to be decreasing in developed countries.2 It often coexists with mitral regurgitation, which is discussed below. Less common causes of MS include congenital defects, malignant carcinoid, systemic lupus erythematosis, and rheumatoid arthritis.

A normal mitral valve has an area of approximately 6 cm2 and allows unimpeded flow from the left atrium to the left ventricle with essentially no pressure gradient between the two chambers. As the valve narrows to less than 2 cm2, left atrial pressure increases as resistance to flow across the valve increases. The increased pres­sure gradient is exacerbated when heart rate increases since short­ened diastole requires higher flow rates across the valve to achieve appropriate LV filling. As a result, patients maj’ experience short­ness of breath with exertion at this stage. Cardiac output may also fail to rise normally with exertion. Other causes of increased heart rate including emotional stress, thyrotoxicosis, and pregnancy can also produce symptoms. Similarly, as LA pressure produces progressive LA enlargement, there is a propensity to develop atrial fibrillation, which may hasten symptoms.

Our use of the term or terms Ocella Lawsuit: is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Ocella Lawsuit: visit our site often.

http://www.seedol.com

Posted in Rankology | Tagged , |

Actos Side Effects Legal News

By admin | Published January 24, 2012

Actos Side Effects : More information on Actos Side Effects

After the initial shock of being given a new diagnosis of cancer, a flood of emotions follow with fear and anxiety being foremost. Questions fill your mind:

How serious is it?

Can 1 be cured?

Am I going to die?

Will I suffer?

What treatments are available?

Can 1 do anything to improve my odds?

What side effects will occur from the treatments?

Will I lose time from work?

Will my insurance cover the cost?

Will I be disfigured?

Will my spouse and family be supportive?

Do 1 have a good doctor?

Bladder cancer, or any serious potentially life threatening illness is generally alien to most individuals. Suddenly, lives are changed and a new reality must be dealt with. Becoming a “patient” or worse “a cancer patient” is not only threatening, but a dreaded proposition. Cancer patients are not happy with the loss of autonomy, the invasion of privacy, the discomfort inflicted upon them and the demands on their time and quality of life. As a patient, being thrust into this altered identity, it is essential to seek out the information you need. Having a fundamental base of knowledge is a must when facing the issues and treatment decisions which lie ahead. In the following pages, together we will explore bladder cancer, a disease which is totally foreign to most of us until the diagnosis is made. I have chosen to present the information in a question and answer format, written in a conversational tone, as if I were having an extended consultation with one of my patients. The questions are typical of what individuals have asked over the years. 1 have covered the key issues and decisions the individual with bladder cancer may face. The answers are to the point and cover the essentials required to make an informed decision for most individuals. For others, a more detailed resource may be required. For helpful sources of additional information see the Appendix.

Each individual’s situation is unique. Decisions on treatment may be modified based on the patient’s preferences and values and altered by other considerations such as age and coexisting conditions. By becoming an individual knowledgeable of bladder cancer, you will be prepared to fully partner with your physician for your best possible outcome. To your companions and family members, this book will serve to answer the many questions and doubts that may arise. Having your loved ones informed and supportive is a big plus for the individual facing this new challenge.

The book is written in a logical sequence starting with finding a qualified urologist to the basics on bladder cancer, its assessment and treatment. At the end of the book, you will find chapters on complementary medicine, advance care planning, and hospice care. The book can be read in sequence or each chapter can serve as a resource covering the basics of the topic. It is my hope this book will help clarify the many issues and options individuals must face with bladder cancer. For family members, significant others and concerned friends, this resource should help improve your understanding and thus your ability to assist your loved one.

 

Information from other sources on Actos Side Effects

Understanding bladder cancer is a tremendous first step that will assist you in your treatment. Having a qualified urologist administer the actual treatments and care for you is essential for the best possible outcome. In the following chapter, we will explore what you need to know to assure you have the right urologist.

BESIDES LEARNING ABOUT MY DISEASE, WHAT IS MY MOST IMPORTANT FIRST STEP?

Make sure you have an excellent urologist supervising your care. A urologist is a surgical specialist trained to care for conditions involving the male and female urinary tracts and the male reproductive system. The bladder is part of the urinary system, and a urologist is trained to care for problems involving it, including cancer.

IS IT IMPORTANT TO HAVE A BOARD CERTIFIED UROLOGIST?

A urologist board certified by The American Board of Urology has gone through an accredited urology training program (generally a four year program), following two years of internship and residency in surgery after four years of medical school. The urologist must be in practice after training and provide a detailed list of surgeries, including complications, over a twelve month period. The doctor will then take a two day oral and written test covering a wide spectrum of urology. If he passes, he is certified for a period of ten years. At the end of the ten year period, he must recertify to maintain his board status. Recertification entails a three month surgical and procedure log and a written test as well as reference letters from those in a position to judge the practicing urologist’s work. Any malpractice or judgments are also reviewed. Although being board certified does not guarantee you have an excellent urologist, it demonstrates that he has the fund of knowledge to practice urology competently. Even though board certification is voluntary, in today’s competitive environment more and more hospitals and insurance plans are requiring their specialists to be certified.

HOW CAN I TELL IF MY UROLOGIST IS BOARD CERTIFIED?

The urologist has worked hard to obtain board certification. The certificate from The American Board of Urology is often displayed openly in his office. If you do not see it, you can simply ask him or you can call 1-866-275-2267 or use this web site: www.certified doctor.org

SHOULD I TRY TO FIND A UROLOGIST WHO HAS BEEN IN PRACTICE FOR YEARS OR A NEWLY TRAINED ONE?

Surgery is a skill which can only be mastered with experience. The saying “practice makes perfect” definitely pertains to surgery. Although a urology training program offers the new physician years of training, his surgical skills will continue to improve with further experience. However, each individual physician has his own innate skills. Some more quickly learn and are simply better at the technical craft of surgery than others. For the most part, urologists finishing an accredited urology program have the training and skill set required to care for patients with bladder cancer.

Experience also counts. As a physician practices the art of medicine, his depth of knowledge and ability to treat grows. Ask your physician how long he has been treating patients with bladder cancer. If you require major surgery ask how many he has performed and if his complication rate matches what is expected.

Physicians by and large do improve as they practice, and all physicians are required to show that they are continuing to learn by partaking in continuing medical education, a requirement to remain licensed. Most physicians are compulsive in their medical practice and care deeply in the care they deliver. They continually strive to improve.

Some physicians may become “burned out” over the years as they continue to face the pressures of a busy medical practice. Similarly, towards the end of a surgeon’s career, technical skills may slip due to aging. New urologists are trained in the latest techniques and are familiar with recent medical literature, but may lack practical experience. In the end, recommendations from others and reputation may be your best guide to finding a qualified physician.

WHAT QUALITIES SHOULD MY UROLOGIST HAVE?

Ideally, you should have a competent, technically skilled surgeon who is also approachable and compassionate. You should be able to freely ask questions pertaining to your disease and treatment. Your physician should answer your questions forthrightly. Although some patients prefer a surgeon who will take over all aspects of care with no questions asked, most prefer in depth explanations, especially when alternatives exist and risks are involved.

Your urologist must be an individual who takes your concerns, priorities and values seriously. Your urologist should be a good communicator. It is his responsibility to keep you fully informed of your progress, make you aware immediately if things are not going well, and educate you fully in treatment alternatives. Your specific values should be incorporated into the decision process if alternatives are available. Even if your urologist makes a recommendation and you choose an alternative course (unless you are putting yourself in extreme jeopardy), he should honor your choice and continue his care of you. Becoming an educated patient will make your decision making process easier. Granted, your physician should provide you with the basics, however having time to review and digest the material will allow you to fully understand and accept your treatment regimen, providing you with peace of mind.

Beware of the physician who bombards you with statistics and studies and leaves the decision making to you. After all, you are not a physician and don’t have the practical hands on experience he does. Your physician should provide the facts and the statistics, guide you through the information, and make treatment recommendations based on your preferences.

You may find yourself emotionally distraught and overwhelmed. Having a physician on your side is invaluable. You should be able to trust your physician. Complete honesty on the part of your doctor in his care of you is a must. From the doctor’s point of view, trust is also a necessity. Physicians have an extremely difficult time dealing with individuals who do not trust them. Without trust, the physician patient relationship is extremely hindered.

Lastly, your urologist should be compassionate. Having cancer is tough enough, you shouldn’t have to deal with a rude or arrogant physician. Your urologist should be supportive at all times. He should treat you as an individual and not just as “another cancer patient.” People with bladder cancer will require long term follow up and care. Having a compassionate individual to work with will make a tremendous difference

HOW DO I FIND A GOOD BOARD CERTIFIED UROLOGIST?

A good starting point is your primary care physician. He will generally have a number of specialists to whom he generally refers his urology patients. If the primary care physician has been working with these urologists, he should have an appreciation of their skills and temperament. However, this does not mean he is referring you necessarily to the best available urologist in your area. His choices may be limited by insurance or hospital networks. An excellent source of information would be nurses who work in the operating room, recovery room or on the surgical floor where the urologist does his surgery. Asking friends or other individuals who have had experience with the urologist can also prove useful. After a little digging, you can often quickly learn what type of reputation the urologist has in the community. Generally, if an established urologist has a “good reputation” this is an indication that he has pleased many individuals with his care.

SHOULD I CHECK TO SEE HOW MANY TIMES MY UROLOGIST HAS BEEN SUED?

Given the litigious society we live in, most physicians can face at least one malpractice lawsuit during their careers. In urology, two of the most common causes of litigation would be a surgical mishap leading to a complication, or failure to diagnose cancer in a timely fashion.

Medicine is based on science, but also is an “art.” Individuals do not walk into their physicians offices with a diagnosis and treatment plan always readily apparent. Even the best intentioned, thorough physician will make mistakes. Most of these errors do not result in harm. On occasion they do, and a law suit may follow. If a physician develops a good working relationship with a patient, these bad outcomes more often than not are acknowledged and accepted without legal entanglement. Competent, busy physicians may be dealing with a higher mix of complicated patients, leading to a higher number of potential suits. Physicians who have poor “bed side manner” may find themselves dealing with more suits. If a physician has an inordinate number of suits, “red flags” should go up, as competency may be an issue.

For those individuals who wish to check out the malpractice history of their physician, you may request an inquiry from the National Practitioners Data Bank at: 1-800-767-6732 or check the web site: www.npdb-hipdb.com

Our use of the term or terms Actos Side Effects is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Actos Side Effects visit our site often.

http://www.seedol.com

Posted in Rankology | Tagged , |